2009 -2012 Senior Clinical Scientist @ Merck Research Laboratories
2009 -2009 Senior Clinical Scientist @
2008 -2009 Project Manager and Scientist @ Spinal Muscular Atrophy Foundation
2003 -2007 Senior Scientist, US Head of Neurochemistry @ Lundbeck Research USA, Inc
2001 -2003 Postdoctoral Fellow @ Eli Lilly
Chad Swanson Education
Medical University of South Carolina
PhD (Neuropharmacology)
1998-2001
(Pharmacology / Toxicology)
University of Wisconsin-Madison
BS (Zoology with Neurobiology emphasis)
Chad Swanson Skills
Drug Discovery
Pharmacology
Clinical Development
Drug Development
Neuroscience
CRO
In Vivo
Pharmaceutical Industry
Clinical Trials
Biotechnology
Lifesciences
Translational Research
Therapeutic Areas
Regulatory Submissions
CTMS
Animal Models
Clinical Research
Clinical Operations
Life Sciences
Medical Writing
Translational Medicine
Chad Swanson Summary
Chad Swanson, based in New York, NY, US, is currently a Chief Development Officer at Prothena Biosciences Inc.. Chad Swanson brings experience from previous roles at Prothena Biosciences Inc., Eisai Inc and Eisai. Chad Swanson holds a 1998 - 2001 PhD in Neuropharmacology @ Medical University of South Carolina. With a robust skill set that includes Drug Discovery, Pharmacology, Clinical Development, Drug Development, Neuroscience and more. Chad Swanson has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Chad Swanson?
Find contact details for 700 million professionals.